Brevan Howard Capital Management’s Eastman Chemical EMN Stock Holding History

Brevan Howard Capital Management’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-30,626	Closed	-$1.93M	–	1927
2025 Q3	$1.93M	Buy	30,626 +26,443	+632%	+$1.85M	0.01%	581
2025 Q2	$312K	Buy	+4,183	New	+$329K	﹤0.01%	1531
2025 Q1	–	Sell	-10,709	Closed	-$978K	–	1245
2024 Q4	$978K	Buy	+10,709	New	+$1.1M	0.01%	441
2024 Q3	–	Sell	-11,394	Closed	-$1.12M	–	1219
2024 Q2	$1.12M	Buy	11,394 +7,209	+172%	+$715K	0.01%	342
2024 Q1	$419K	Buy	+4,185	New	+$368K	﹤0.01%	513

Other funds holding EMN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brevan Howard Capital Management's EMN Position: Q4 2025 in Review

Brevan Howard Capital Management sold out of Eastman Chemical (EMN) in Q4 2025, closing a stake of 30,626 shares — an estimated $1.93M sold.

Brevan Howard Capital Management first reported a position in EMN in Q1 2024 and held it in 5 quarters. The position peaked at $1.93M in Q3 2025. 630 funds tracked by Wall St. Rank hold EMN as of Q4 2025.

Brevan Howard Capital Management reported no remaining Eastman Chemical position as of Q4 2025 after selling out during the quarter.
Brevan Howard Capital Management sold 30,626 Eastman Chemical shares in Q4 2025, an estimated $1.93M.
Brevan Howard Capital Management first reported a position in Eastman Chemical in Q1 2024 and held it in 5 quarters.
Brevan Howard Capital Management's Eastman Chemical position peaked at $1.93M in Q3 2025.
630 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2025.

Based on Brevan Howard Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.